Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
Nature Medicine2017Vol. 23(11), pp. 1362–1368
Citations Over TimeTop 1% of 2017 papers
Rodrigo Romero, Volkan I. Sayin, Shawn M. Davidson, Matthew R. Bauer, Simranjit X. Singh, Sarah E. LeBoeuf, Triantafyllia Karakousi, Donald C Ellis, Arjun Bhutkar, Francisco J. Sánchez‐Rivera, Lakshmipriya Subbaraj, Britney Martinez, Roderick T. Bronson, Justin R. Prigge, Edward E. Schmidt, Craig J. Thomas, Chandra Goparaju, Angela M. Davies, Igor Dolgalev, Adriana Heguy, Viola Allaj, John T. Poirier, André L. Moreira, Charles M. Rudin, Harvey I. Pass, Matthew G. Vander Heiden, Tyler Jacks, Thales Papagiannakopoulos
Related Papers
- → Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies(2020)177 cited
- → Nitrogen anabolism underlies the importance of glutaminolysis in proliferating cells(2010)85 cited
- → Non-Coding RNAs as Key Regulators of Glutaminolysis in Cancer(2020)33 cited
- → Pyruvate Kinase M2 Coordinates Metabolism Switch between Glycolysis and Glutaminolysis in Cancer Cells(2020)26 cited
- → Androgen Signaling Restricts Glutaminolysis to Drive Sex-Specific Th17 Metabolism(2023)